https://www.selleckchem.com/pr....oducts/Maraviroc.htm
Current guidelines recommend considering aCFT in patients with INOCA and persistent symptoms. The safety of the procedure is comparable to that of aregular coronary angiography with physiological measurements. Non-invasive alternatives have limited diagnostic accuracy for the identification of coronary vascular dysfunction in patients with INOCA, and aregular coronary angiography and/or coronary computed tomography scan cannot establish the diagnosis. Acomplete CFT, including acetylcholine and adenosine tests, should be considered in